Yolande Hanssens
Overview
Explore the profile of Yolande Hanssens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
251
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salem W, Abdulrouf P, Thomas B, Elkassem W, Abushanab D, Rahman Khan H, et al.
J Pharm Policy Pract
. 2024 May;
17(1):2325513.
PMID: 38741897
Introduction: Poisoning is a major public health issue and a leading cause of admission to the emergency department (ED). There is a paucity of data describing the epidemiology and cost...
2.
Abushanab D, Al-Marridi W, Al Hail M, Abdul Rouf P, Elkassem W, Thomas B, et al.
J Pharm Policy Pract
. 2024 Mar;
17(1):2326382.
PMID: 38549684
Objective: To estimate the economic impact of the developed antimicrobial stewardship program (ASP) versus the preliminary ASP use, in the adults' general medicine settings in Qatar. Methods: Patient records were...
3.
Abushanab D, Gasim M, Devi D, Elbdairy M, Elqasass H, Ahmed N, et al.
Medicine (Baltimore)
. 2023 Sep;
102(38):e34872.
PMID: 37746996
We aimed to investigate the characteristics and clinical outcomes of paracetamol poisoning and paracetamol overdose in Qatar. This retrospective cohort study included patients admitted to the emergency department (ED). We...
4.
Nazar Z, Al Hail M, Al-Shaibi S, Hussain T, Abdelkader N, Pallivalapila A, et al.
Int J Clin Pharm
. 2023 Jul;
45(6):1424-1433.
PMID: 37454024
Background: Well-designed and well-maintained drug formularies serve as a reliable resource to guide prescribing decisions; they are associated with improved medicine safety and increased efficiency, while also serving as a...
5.
Hamad A, Elazzazy S, Bujassoum S, Rasul K, Gaziev J, Cherif H, et al.
BMC Health Serv Res
. 2023 Jan;
23(1):15.
PMID: 36609388
Background: In line with global trends, cancer incidence and mortality may have decreased for specific types of cancer in Qatar. However, the cancer-related burden on patients, healthcare systems, and the...
6.
A scoping review of theories used to investigate clinician adherence to clinical practice guidelines
Stewart D, Al Hail M, Al-Shaibi S, Hussain T, Abdelkader N, Pallivalapila A, et al.
Int J Clin Pharm
. 2022 Nov;
45(1):52-63.
PMID: 36385205
Background: Routine utilization of evidence-based clinical practice guidelines (CPGs) is an effective strategy to optimize patient care and reduce practice variation. Healthcare professionals' failure to adhere to CPGs introduces risks...
7.
Stewart D, Pallivalapila A, Thomas B, Hanssens Y, El Kassem W, Nazar Z, et al.
Int J Clin Pharm
. 2021 Jun;
43(6):1638-1650.
PMID: 34125372
Background Studies have highlighted advancing clinical pharmacy practice in Qatar. Objective To explore pharmacists' aspirations and readiness to implement pharmacist prescribing. Setting Hamad Medical Corporation (HMC), the main provider of...
8.
Canibano B, Deleu D, Mesraoua B, Melikyan G, Ibrahim F, Hanssens Y
J Drug Assess
. 2020 Mar;
9(1):20-36.
PMID: 32128285
To review the current evidence regarding pregnancy-related issues in multiple sclerosis (MS) and to provide recommendations specific for each of them. A systematic review was performed based on a comprehensive...
9.
Canibano B, Ali M, Mesraoua B, Melikyan G, Al Hail H, Ibrahim F, et al.
Case Rep Womens Health
. 2019 Dec;
25:e00162.
PMID: 31867224
Although pregnancy is potentially protective against relapses of multiple sclerosis, severe rebound of disease activity after withdrawal of fingolimod may occur. We report a woman with multiple sclerosis who discontinued...
10.
Martin L, Hanssens Y, Paudyal V
Int J Clin Pharm
. 2018 Aug;
40(4):737-739.
PMID: 30132234
No abstract available.